RA Capital Nexus Fund IV, Director: Hemab Therapeutics Holdings COAG Buy · Filed 05/06

Trade details

Type: Insider buy
Amount: $256,700
Shares · price: 10,268 sh · $25.00 a share
Held after: 6,246,507 sh
Stock: Hemab Therapeutics Holdings COAG
Person: RA Capital Nexus Fund IVDirector
Trade date: 26/05/05
Filed: 26/05/06
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 6 insiders
Holding change: +0.2%

Hemab Therapeutics Holdings trades, last 26 weeks

What else happened in Hemab Therapeutics Holdings around then

Filed or reported within 30 days of the trade day · 04/05~06/04

RA Capital Nexus Fund IV's recent trades

RA Capital Nexus Fund IVDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IVDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IVDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IVDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IVDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06